# Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

> **NCT04885452** · — · COMPLETED · sponsor: **ANRS, Emerging Infectious Diseases** · enrollment: 756 (actual)

## Conditions studied

- SARS-CoV Infection
- Covid19

## Interventions

- **OTHER:** biobank

## Key facts

- **NCT ID:** NCT04885452
- **Lead sponsor:** ANRS, Emerging Infectious Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-21
- **Primary completion:** 2023-06-18
- **Final completion:** 2023-12-18
- **Target enrollment:** 756 (ACTUAL)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885452, "Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04885452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*